Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

類似資料

• A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.
  著者:: Gietema, J. A., 等
  出版事項: (1993)
• Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin
  著者:: Jong, R S de, 等
  出版事項: (1999)
• Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.
  著者:: Veldhuis, G. J., 等
  出版事項: (1997)
• Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
  著者:: de Jong, R. S., 等
  出版事項: (1997)
• A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.
  著者:: de Vries, E. G., 等
  出版事項: (1993)